<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Croatian Society for Medical Biochemistry and Laboratory Medicine</publisher>
				<availability status="unknown"><p>Copyright Croatian Society for Medical Biochemistry and Laboratory Medicine</p>
				</availability>
				<date type="published" when="2012">2012</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasemin</forename><forename type="middle">U</forename><surname>Budak</surname></persName>
							<email>yaseminbudak2000@yahoo.com</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Laboratory</orgName>
								<orgName type="institution">Sevket Yilmaz Education and Training Hospital</orgName>
								<address>
									<settlement>Bursa</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kagan</forename><surname>Huysal</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Murat</forename><surname>Polat</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of General Surgery</orgName>
								<orgName type="institution">Sevket Yilmaz Education and Training Hospital</orgName>
								<address>
									<settlement>Bursa</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gülsevil</forename><surname>Tarakçi</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hakan</forename><surname>Uçar</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Sevket Yilmaz Education and Training Hospital</orgName>
								<address>
									<settlement>Bursa</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Biochemia Medica</title>
						<title level="j" type="abbrev">Biochem Med</title>
						<idno type="eISSN">1846-7482</idno>
						<imprint>
							<publisher>Croatian Society for Medical Biochemistry and Laboratory Medicine</publisher>
							<biblScope unit="page" from="121" to="126"/>
							<date type="published" when="2012" />
						</imprint>
					</monogr>
					<idno type="DOI">10.11613/bm.2012.014</idno>
					<ptr type="open-access" target="https://www.biochemia-medica.com/assets/images/upload/xml_tif/Budak_YU__et_al_-Evaluation_of_PT-INR_assay.pdf" />
					<note type="submission">Received: August 15, 2011 Accepted: December 28, 2011</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:55+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Steelex coagulometer; prothrombin time</term>
					<term>INR</term>
					<term>evaluation</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Introduction: The aim of the present study was to validate prothrombin time (PT) international normalized ratio (INR) results obtained using Steelex test reagents and a Steelex coagulometer (Steelex Scientifi c Instrument Company, Beijing, China), in comparison with use of a well-established standard test employing Pacifi c Hemostasis reagents (Fisher Diagnostics, Middletown, VA, USA) and Teco Coatron A4 coagulometer (Teco Medical Instruments GmbH, Neufahrn, Germany). Materials and methods: Between-and within-day coeffi cients of variation (CVs) of both assays were calculated using control samples provided by the test manufacturers. Samples from 90 subjects were collected and INR values were determined in a double-blind parallel manner employing both systems. Results: The within-day coeffi cients of variation (CVs) in INR estimates ranged from 2.6% (INR = 1.12) to 3.1% (INR = 2.51) for the Steelex system and from 2.1% (INR = 1.09) to 1.8% (INR = 2.8) for the Pacifi c test; the between-day values ran from 3.4% (INR = 1.16) to 7.9% (INR = 2.64) and from 3.3% (INR = 1.1) to 2.3% (INR = 2.7), respectively. Passing-Bablok fi t of the of the Steelex and Pacifi c methods yielded the equation: Steelex INR = 0.85 (0.79-0.91) × Pacifi c INR + 0.12 (-0.02-0.21), whereas the CUSUM linearity P value was &lt; 0.01. The mean bias as determined by the Bland-Altman test was-0.156 (-0.912-0.600). Conclusion: The results obtained using Steelex reagents and the M600H coagulometer are not equivalent to those obtained using Pacifi c Hemostasis reagents and a Teco Coatron A4 coagulometer, at least in the therapeutic range.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Prothrombin time (PT) is the most common coagulation test performed in the clinical laboratory. PT is used to detect abnormalities in the extrinsic coagulation pathway. PT measurement is critical when thrombotic patients are on oral anticoagulant therapy. However, it can be diffi cult to compare PT test results from diff erent laboratories (1); standardization is essential. Thromboplastin, the principal reagent of the PT assay, is commercially available in diff erent forms. To achieve the required standardization, all thromboplastin preparations should be calibrated using the Internation-al Sensitivity Index (ISI) and PT results should be presented in International Normalized Ratio (INR) units <ref type="bibr" target="#b1">(2)</ref>. The WHO Expert Committee on Biological Standardization has decreed that standardization requires a comparison of results yielded by the test thromboplastin with those aff orded when a reference thromboplastin is employed <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b2">3)</ref>. However, it is clear that standardization is not universally performed <ref type="bibr" target="#b4">(4)</ref><ref type="bibr" target="#b5">(5)</ref><ref type="bibr" target="#b6">(6)</ref><ref type="bibr">(7)</ref>.</p><p>In Turkey, public procurement law requires that the lowest bid be accepted when equipment or reagents are ordered. Thus, the choice of a coagu- <ref type="bibr">Budak YU. et</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p>The present study was conducted in the period from June to July 2011 in the clinical laboratory of the Şevket Yılmaz Research and Education Hospital. The study was approved by our institutional Ethics Committee and all participants gave written informed consent. All procedures were in accordance with the Second Declaration of Helsinki.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PT and INR determination methods</head><p>As a reference method, plasma PT was analyzed in an automated manner using a Teco Coatron A4 coagulator. The PT of citrated plasma was determined photometrically employing a high-resolution four-channel optic system (400 nm) and a suspension of rabbit brain thromboplastin (Thromboplastin-DS) prepared in calcium chloride solution.  <ref type="bibr" target="#b8">(8)</ref>. The INR is calculated and automatically displayed by the instruments from the prothrombin time using the formula <ref type="formula">3</ref>:</p><formula xml:id="formula_0">INR = (PT sample /PT normal ) ISI</formula><p>The coeffi cients of variation of the regression line slopes of calibration curves of both instruments were less than 3%, in accordance with the WHO requirements <ref type="bibr" target="#b9">(9)</ref>. All INRs were calculated using a local prothrombin time (PT); this was the mean normal prothrombin time (MNPT) obtained using 20 fresh normal samples from healthy individuals <ref type="bibr" target="#b10">(10)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analytical precision of PT and INR determinations</head><p>Before specimen analysis, we performed two-level quality-control (QC) tests using materials supplied by either manufacturer (Steelex ANCP, catalog no. SS005711001 and NCP, catalog no. SS000500007; Pacifi c Hemostasis INR Control Plasma catalog nos. 100595 and 100596). Between-day diff erences in QC data were determined via analysis of duplicates on each of 20 successive days. Within-day precision was calculated by conducting 20 replicate analyses of the QC materials in a single run. Between-day precision is a measure of random analytical error <ref type="bibr" target="#b12">(11)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and blood sampling</head><p>Venous blood samples were obtained from 90 patients for whom PT (INR) tests were scheduled as part of routine preoperative check-up (N = 14) or for monitoring of oral anticoagulant therapy (OAT) (N = 76). Patients with atrial fi brillation and/or a prosthet-ic heart valve, and those prescribed long-term OAT were accepted to the study. Of all patients, 35 were in their fi rst 3 months of treatment (the dose-adjustment phase) whereas 41 were in a later treatment stage (the maintenance phase  <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b13">12)</ref>. Plasma was obtained via centrifugation for 15 min at 1,500 x g. All samples were assayed using the two systems within 1 hour of blood collection.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Data were evaluated using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) and Analyse-It version 2.04 (Analyse-It Software, Leeds, UK). Means, standard deviations, and coeffi cients of variation were calculated. <ref type="bibr" target="#b14">(13)</ref><ref type="bibr" target="#b15">(14)</ref><ref type="bibr" target="#b16">(15)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The coeffi cients of variation (CVs) of within-and between-day QC data are presented in <ref type="table" target="#tab_4">Table 1</ref>.</p><p>Passing and Bablok regression analysis yielded an intercept of 0.12 units (95% confi dence interval (CI) = -0.02-0.21) and a slope of 0.85 (95% CI = 0.79-0.91), suggesting that, a proportional diff erence existed between the two methods ( <ref type="figure" target="#fig_0">Figure 1</ref>) <ref type="bibr" target="#b15">(14)</ref>.</p><p>The cumulative sum linearity test (CUSUM test) revealed signifi cant deviation from linearity (P &lt; 0.01) <ref type="bibr" target="#b15">(14)</ref>.</p><p>The Bland-Altman diff erence plot showed that the mean bias was -0.156 units and the 95% limits of agreement were -0.912 to 0.600 when the Steelex and Pacifi c test data were compared ( <ref type="figure" target="#fig_1">Figure 2</ref>). The bias was lower in the sub-therapeutic range (INR &lt; 2.0) and higher in the therapeutic range (INR = 2.0-4.5) ( <ref type="figure" target="#fig_0">Figure 1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Extensive international collaboration has allowed laboratory INR measurement to become standardized worldwide; this is an essential feature of quality control <ref type="bibr" target="#b17">(16,</ref><ref type="bibr" target="#b18">17)</ref>.  We consider that the Pacifi c system is a suitable standard for use in validation studies as this method yielded acceptable quality control data during our study period and employs highly sensitive human thromboplastin (ISI = 1.03), as recommended by the College of American Pathologists <ref type="bibr" target="#b13">(12)</ref>.</p><p>Within-run imprecision was satisfactory for both systems (CV ≤ 3.1%). The Steelex system had a higher between-run CV than did the Pacifi c method, explained by the fact that use of reagents of higher ISI is associated with greater interlaboratory INR CVs <ref type="bibr" target="#b19">(18)</ref>. The level of between-run imprecision using the Steelex system (Level 2; CV = 7.9%) was unacceptable; the value should be less than 5% when an INR assay is performed <ref type="bibr" target="#b20">(19)</ref>.</p><p>Monitoring of PT via calculation of INRs is important for patients on oral anticoagulation therapy; appropriate doses can thus be prescribed. Accurate INR estimation is crucial <ref type="bibr" target="#b21">(20)</ref>. Global harmonization of INR results, and agreement on the therapeutic ranges associated with varying clinical indications, is important <ref type="bibr" target="#b22">(21)</ref>. Many factors infl uence INR values; these include the levels of various coagulation factors present and their interaction with thromboplastin reagents diff ering in composition and sensitivity to the actions of such factors <ref type="bibr" target="#b23">(22)</ref>. It can be diffi cult to obtain accurate and precise INR measurements. Both PT and INR data should be identical regardless of the reagents, instrument, or test method used. However, agreement among results yielded by many commercial INR methods is poor. Such variations may compromise patient care <ref type="bibr" target="#b0">(1,</ref><ref type="bibr">7)</ref>.</p><p>In our present work; Passing and Bablok regression analysis yielded the appropriate y-intercept value of zero but the slope of the regression line did not approximate unity, suggesting that, in addition to the presence of a small constant bias, a proportional diff erence existed between the two methods <ref type="bibr" target="#b15">(14)</ref>. Our results are in agreement with previous fi ndings of poor agreement among data obtained using diff erent methods to calculate PT and INR <ref type="bibr">(7,</ref><ref type="bibr" target="#b24">23)</ref>. The variation noted in the present work may be attributable to diff erences between any or all of methodology, the coagulometers used, and thromboplastin source.  bias relative to the consensus group. It provides a good measure of accuracy because each laboratory's results are compared to the mean value for all laboratories, which is assumed to be the true value.</p><p>Budak YU. et al.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of PT-INR assay</head><p>and unpredictable eff ect on INR value <ref type="bibr" target="#b25">(24)</ref>. The precision of PT testing tends to be greater when ISI is lower (24) but end-point reliability is also affected by reagent quality <ref type="bibr" target="#b25">(24)</ref>.</p><p>Quality control is essential; it is recommended that analytical imprecision be less than or equal to half of intra-individual biological variation <ref type="bibr" target="#b26">(25)</ref><ref type="bibr" target="#b27">(26)</ref><ref type="bibr" target="#b28">(27)</ref>. <ref type="bibr">Ricos et al. (28)</ref> found intra-individual INR variation of 4% and inter-individual variation of 6.8%. Kjeldsen (29) recorded in-treatment intra-individual INR variation of 10.1%. Via computer simulation of serial INR measurements within the generally accepted therapeutic range (INR 2.0-3.0), the cited author concluded that analytical imprecision should be less than 5% and analytical bias less than ± 0.2 INR units <ref type="bibr" target="#b30">(29)</ref>. In the present study, the overall analytical bias was indeed less than ± 0.2 INR units, but, in the therapeutic range, the bias was greater than ± 0.2 INR units, thus signifi cantly higher than current recommendations <ref type="bibr" target="#b29">(28,</ref><ref type="bibr" target="#b30">29)</ref>. It is evident that ISI strongly infl uences INR inter-laboratory variability <ref type="bibr" target="#b31">(30)</ref>. Although the ISI assigned by the manufacturer of the Steelex M600H coagulometer was relatively low (1.18), a major limitation of our study is that local ISI calibration using WHO-certifi ed plasma was not performed. Incorrect assignment of ISI values by manufacturers may cause among-method diff erences in test results.</p><p>In particular, we found that INR data obtained using either the Steelex PT or Pacifi c reagents were in acceptable agreement in patients with INR values close to 1, but variance within the therapeutic range (INR 2.0-4.5) was unacceptable, with an analytical bias over 0. <ref type="bibr">20 INR units (19,</ref><ref type="bibr" target="#b30">29)</ref> being evident in twenty eight out of 90 patients. Similarly, Horsti et al. <ref type="bibr">(7)</ref> found that INR values obtained using different methods were very similar when such values were close to unity but marked variations were evident at higher INR values. This is unacceptable, because bias of this magnitude may result in prescription of incorrect amounts of anticoagulation agents <ref type="bibr" target="#b9">(9)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>In conclusion, reliable PT, INR test data are important for proper management of patients on OAT.</p><p>Our results indicate that results obtained from Steelex M600H coagulometer using Steelex reagents kit are not interchangeable with Teco Coatron A4 coagulation coagulometer using Pacifi c Hemostasis reagent kit, in the therapeutic range.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc>Many recent reports have shown that coagulometer choice has a marked INR Passing-Bablok regression analysis for the Steelex INR results vs. laboratory (Pacifi c) INR results. The solid line indicates the regression line.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 2 .</head><label>2</label><figDesc>Bland-Altman plot analysis between compaired methods.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc>al. Evaluation of PT-INR assaylometer is price-dependent, even though the accuracy and reliability of INR measurement is essential. The Steelex M600H (Steelex Scientifi c Instrument Company, Beijing, China), approved for use in our laboratory because the device is inexpensive, is a new coagulometer that measures PT and INR.</figDesc><table><row><cell>The aim of the present study was to validate INR</cell></row><row><cell>results obtained using the Steelex M600H coagu-</cell></row><row><cell>lometer and Steelex reagents (the PT kit) by com-</cell></row><row><cell>paring such data with the results yielded by a Teco</cell></row><row><cell>Coatron A4 coagulometer (Teco Medical Instru-</cell></row><row><cell>ments GmbH, Neufahrn, Germany) employing a</cell></row><row><cell>Pacifi c Hemostasis test reagent (Thromboplastin-</cell></row><row><cell>DS, Fisher Diagnostics, VA, USA). The latter test is</cell></row><row><cell>standard in the clinical laboratory.</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE 1 :</head><label>1</label><figDesc>Within-day imprecision data and between-day imprecision data for Steelex test reagent on Steelex M600H coagulometerand Pacifi c Hemostasis test reagents on Teco Coatron A4 coagulometer.</figDesc><table><row><cell></cell><cell></cell><cell cols="3">Steelex test reagents</cell><cell></cell><cell cols="3">Pacifi c Hemostasis test reagents</cell><cell></cell></row><row><cell></cell><cell></cell><cell>Within-Day Mean (SD) (N = 20)</cell><cell>CV (%)</cell><cell>Between-Day Mean (SD) (N = 20)</cell><cell>CV (%)</cell><cell>Within-Day Mean (SD) (N = 20)</cell><cell>CV (%)</cell><cell>Between-Day (N = 20) Mean (SD)</cell><cell>CV (%)</cell></row><row><cell>QC1*</cell><cell>PT(sec)</cell><cell>13.8 (0.36)</cell><cell>2.6</cell><cell>14.2 (0.49)</cell><cell>3.4</cell><cell>15.1 (0.32)</cell><cell>2.1</cell><cell>15.2 (0.49)</cell><cell>3.2</cell></row><row><cell></cell><cell>INR</cell><cell>1.12 (0.03)</cell><cell>2.6</cell><cell>1.16 (0.04)</cell><cell>3.4</cell><cell>1.09 (0.02)</cell><cell>2.1</cell><cell>1.1 (0.03)</cell><cell>3.3</cell></row><row><cell>QC2**</cell><cell>PT(sec)</cell><cell>27.2 (0.71)</cell><cell>2.6</cell><cell>28.8 (2.19)</cell><cell>7.6</cell><cell>37.6 (0.68)</cell><cell>1.8</cell><cell>37.3 (0.86)</cell><cell>2.3</cell></row><row><cell></cell><cell>INR</cell><cell>2.51 (0.08)</cell><cell>3.1</cell><cell>2.64 (0.21)</cell><cell>7.9</cell><cell>2.8 (0.05)</cell><cell>1.8</cell><cell>2.7 (0.07)</cell><cell>2.5</cell></row><row><cell cols="3">*QC1, *QC2 = quality control level 1 and level 2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>We did not receive any funding for this study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential confl ict of interest</head><p>None declared.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Has the Time Arrived to Replace the Quick Prothrombin Time Test for Monitoring Oral Anticoagulant Therapy?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Esnouf</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2004.045393</idno>
		<idno type="PMID">15738512</idno>
		<ptr type="open-access" target="http://clinchem.aaccjnls.org/content/51/3/483.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry</title>
		<title level="j" type="abbrev">Clinical Chemistry</title>
		<idno type="ISSN">0009-9147</idno>
		<idno type="ISSNe">1530-8561</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="483" to="485" />
			<date type="published" when="2005-03-01" />
			<publisher>American Association for Clinical Chemistry (AACC)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">WHO Expert Committee on Biological Standardisation. Thirty-third Report. Technical Report Series</title>
		<imprint>
			<biblScope unit="volume">687</biblScope>
			<date type="published" when="1983" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m">International Committee for Standardisation in Haematology. International Committee On Thrombosis and Haemostastis</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control</title>
	</analytic>
	<monogr>
		<title level="j">Thromb Haemost</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page">155</biblScope>
			<date type="published" when="1985" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The Reliability of Manufacturer-determined, Instrument-specific International Sensitivity Index Values for Calculating the International Normalized Ratio</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">T</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">F</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beverly</forename><forename type="middle">J</forename><surname>Pennell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">D</forename><surname>Olson</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcp/102.1.128</idno>
		<idno type="PMID">8037159</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Clinical Pathology</title>
		<title level="j" type="abbrev">Am J Clin Pathol</title>
		<idno type="ISSN">0002-9173</idno>
		<idno type="ISSNe">1943-7722</idno>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="128" to="133" />
			<date type="published" when="1994-07-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Correction of instrument and reagent based diff erences in determination of the international normalized ratio (INR) for monitoring anticoagulant therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Van Rijn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">P</forename><surname>Rutten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="840" to="843" />
			<date type="published" when="1989" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Failure of the International Normalized Ratio to Generate Consistent Results Within a Local Medical Community</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valerie</forename><forename type="middle">L</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jack</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laurence</forename><surname>Corash</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><forename type="middle">L</forename><surname>Gottfried</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcp/99.6.689</idno>
		<idno type="PMID">8322703</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Clinical Pathology</title>
		<title level="j" type="abbrev">Am J Clin Pathol</title>
		<idno type="ISSN">0002-9173</idno>
		<idno type="ISSNe">1943-7722</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="689" to="694" />
			<date type="published" when="1993-06" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Poor Agreement among Prothrombin Time International Normalized Ratio Methods: Comparison of Seven Commercial Reagents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Horsti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Uppa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vilpo</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2004.043836</idno>
		<idno type="PMID">15665046</idno>
		<ptr type="open-access" target="http://clinchem.aaccjnls.org/content/51/3/553.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry</title>
		<title level="j" type="abbrev">Clinical Chemistry</title>
		<idno type="ISSN">0009-9147</idno>
		<idno type="ISSNe">1530-8561</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="553" to="560" />
			<date type="published" when="2005-03-01" />
			<publisher>American Association for Clinical Chemistry (AACC)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Long-Term French Experience in INR Standardization by a Procedure Using Plasma Calibrants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lucie</forename><forename type="middle">L</forename><surname>Houbouyan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alain</forename><forename type="middle">F</forename><surname>Goguel</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcp/108.1.83</idno>
		<idno type="PMID">9208983</idno>
		<ptr type="open-access" target="https://academic.oup.com/ajcp/article-pdf/108/1/83/24879582/ajcpath108-0083.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Clinical Pathology</title>
		<idno type="ISSN">0002-9173</idno>
		<idno type="ISSNe">1943-7722</idno>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="83" to="89" />
			<date type="published" when="1997-07-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Annex 3: guidelines for thromboplastins and plasma used to control oral anticoagulant therapy</title>
	</analytic>
	<monogr>
		<title level="m">World Health Organization Technical Report Series. 48th report</title>
		<meeting><address><addrLine>Geneva, Switzerland</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1999" />
			<biblScope unit="page" from="64" to="93" />
		</imprint>
	</monogr>
	<note>WHO Expert Committee on Biological Standardization</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Determination of the Mean Normal Prothrombin Time for Assessment of International Normalized Ratios</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Van Den Besselaar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">M</forename><surname>Olthuis</surname></persName>
		</author>
		<idno type="DOI">10.1055/s-0038-1646435</idno>
	</analytic>
	<monogr>
		<title level="j">Thrombosis and Haemostasis</title>
		<title level="j" type="abbrev">Thromb Haemost</title>
		<idno type="ISSN">0340-6245</idno>
		<idno type="ISSNe">2567-689X</idno>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">04</biblScope>
			<biblScope unit="page" from="442" to="445" />
			<date type="published" when="1991-10" />
			<publisher>Georg Thieme Verlag KG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Evaluation of PT-INR assay</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">U</forename><surname>Budak</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Criteria for judging precision and accuracy in method development and evaluation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">O</forename><surname>Westgard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">N</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="825" to="858" />
			<date type="published" when="1974" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Fairweather</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ansell</forename><forename type="middle">J</forename><surname>Van Den Besselaar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Brandt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Bussey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">I</forename><surname>Poller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pathol Lab Med</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="768" to="81" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Statistical methods for assessing agreement between two methods of clinical measurement</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Martin</forename><surname>Bland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijnurstu.2009.10.001</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Nursing Studies</title>
		<title level="j" type="abbrev">International Journal of Nursing Studies</title>
		<idno type="ISSN">0020-7489</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="931" to="936" />
			<date type="published" when="2010-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Comparison of methods: Passing and Bablok regression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lidija</forename><surname>Bilic-Zulle</surname></persName>
		</author>
		<idno type="DOI">10.11613/bm.2011.010</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemia Medica</title>
		<title level="j" type="abbrev">Biochem Med</title>
		<idno type="ISSNe">1846-7482</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="49" to="52" />
			<date type="published" when="2011" />
			<publisher>Croatian Society for Medical Biochemistry and Laboratory Medicine</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Quality in the analytical phase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oswald</forename><surname>Sonntag</surname></persName>
		</author>
		<idno type="DOI">10.11613/bm.2010.017</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemia Medica</title>
		<title level="j" type="abbrev">Biochem Med</title>
		<idno type="ISSNe">1846-7482</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="147" to="153" />
			<date type="published" when="2010" />
			<publisher>Croatian Society for Medical Biochemistry and Laboratory Medicine</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">On behalf of the Subcommittee on Control of Anticoagulation of the Scientifi c and Standardization Committee of the ISTH. Guidelines on preparation, certifi cation, and use of certifi ed plasmas for ISI calibration and INR determination</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Van Den Besselaar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Barrowcliff E Tw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Houbouyan-Réveillard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Poller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tripodi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thromb Haemost</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1946" to="53" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Laboratory reporting of the international normalized ratio: progress and problems</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Brandt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">L</forename><surname>Chandler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">M</forename><surname>Van Cott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">T</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">E</forename><surname>Hayes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pathol Lab Med</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="1641" to="1648" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The value of plasma calibrants in correcting coagulometer effects on international normalized ratios???an international multicentre study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leon</forename><surname>Poller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">A</forename><surname>Triplet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jack</forename><surname>Hirsh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keith</forename><surname>Clarke</surname></persName>
		</author>
		<idno type="DOI">10.1097/00001721-199504000-00063</idno>
	</analytic>
	<monogr>
		<title level="j">Blood Coagulation &amp; Fibrinolysis</title>
		<title level="j" type="abbrev">Blood Coagulation &amp; Fibrinolysis</title>
		<idno type="ISSN">0957-5235</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">171</biblScope>
			<date type="published" when="1995-04" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">One-stage prothrombin time (PT) Test and activated partial thromboplastin time (aPTT) test: Approved Guideline</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">F</forename><surname>Arkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Adcock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Day</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Joist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">G</forename><surname>Lenahan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NCCLS</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1" to="26" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Self-management of oral anticoagulation therapy--methodological and clinical aspects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">D</forename><surname>Christensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dan Med Bull</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page">4284</biblScope>
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Comparison of Quick and Owren Prothrombin Time with Regard to the Harmonisation of the International Normalised Ratio (INR) System</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juha</forename><surname>Horsti</surname></persName>
		</author>
		<idno type="DOI">10.1515/cclm.2002.064</idno>
		<idno type="PMID">12059082</idno>
		<idno type="ark">ark:/67375/QT4-Q45C3NZM-G</idno>
		<idno type="istexId">C4A38D9913A1E56024B812A524D8FC3383B3885B</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry and Laboratory Medicine</title>
		<idno type="ISSN">1434-6621</idno>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="399" to="403" />
			<date type="published" when="2002-01-24" />
			<publisher>Walter de Gruyter GmbH</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Standardization of the INR: How Good Is Your Laboratory&apos;s INR and Can It Be Improved?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emmanuel</forename><surname>Favaloro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dorothy</forename><surname>Adcock</surname></persName>
		</author>
		<idno type="DOI">10.1055/s-0028-1104538</idno>
		<idno type="PMID">19085760</idno>
	</analytic>
	<monogr>
		<title level="j">Seminars in Thrombosis and Hemostasis</title>
		<title level="j" type="abbrev">Semin Thromb Hemost</title>
		<idno type="ISSN">0094-6176</idno>
		<idno type="ISSNe">1098-9064</idno>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">07</biblScope>
			<biblScope unit="page" from="593" to="603" />
			<date type="published" when="2008-10" />
			<publisher>Georg Thieme Verlag KG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Craig</forename><forename type="middle">M</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Peter</forename><surname>Esnouf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomas</forename><forename type="middle">L</forename><surname>Lindahl</surname></persName>
		</author>
		<idno type="DOI">10.1159/000071641</idno>
		<idno type="PMID">12853712</idno>
	</analytic>
	<monogr>
		<title level="j">Pathophysiology of Haemostasis and Thrombosis</title>
		<title level="j" type="abbrev">Pathophysiol Haemos Thromb</title>
		<idno type="ISSN">1424-8832</idno>
		<idno type="ISSNe">1424-8840</idno>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="51" />
			<date type="published" when="2003" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">International Normalized Ratios (INR): the first 20 years</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Poller</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1538-7836.2004.00775.x</idno>
		<idno type="PMID">15140114</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Thrombosis and Haemostasis</title>
		<title level="j" type="abbrev">J Thromb Haemost</title>
		<idno type="ISSN">1538-7933</idno>
		<idno type="ISSNe">1538-7836</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="849" to="860" />
			<date type="published" when="2004-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Interpretation of serial measurements of internalized normalized ratio for prothrombin times in monitoring oral anticoagulant therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Lassen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kjeldsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Antonsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Brandslund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1171" to="1177" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Determination of critical diff erence and probability of signifi cant change in consecutive measurements of International Normalized Ratio (INR) from patients on oral anticoagulant therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Lassen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Brandslund</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Antonsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="444" to="451" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Application of biological variation - a review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmen</forename><surname>Ricos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmen</forename><surname>Perich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joana</forename><surname>Minchinela</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Virtudes</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margarita</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmen</forename><surname>Biosca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marivi</forename><surname>Domenech</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pilar</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos-Victor</forename><surname>Jimenez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jose</forename><forename type="middle">Vicente</forename><surname>Garcia-Lario</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><surname>Cava</surname></persName>
		</author>
		<idno type="DOI">10.11613/bm.2009.023</idno>
		<ptr type="open-access" target="https://www.biochemia-medica.com/assets/images/upload/xml_tif/Ricos_C__et_al_-_Application_of_biological_variation_-_a_review.pdf" />
	</analytic>
	<monogr>
		<title level="j">Biochemia Medica</title>
		<title level="j" type="abbrev">Biochem Med</title>
		<idno type="ISSNe">1846-7482</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="250" to="259" />
			<date type="published" when="2009" />
			<publisher>Croatian Society for Medical Biochemistry and Laboratory Medicine</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Current databases on biological variation: pros, cons and progress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ricos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Cava</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">V</forename><surname>García-Lario</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Hernández</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">V</forename><surname>Jiménez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Clin Lab Invest</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="337" to="386" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Biological variation of International Normalised Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kjeldsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Lassen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Brandslund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="2175" to="82" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalised ratios (INR)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Taberner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Poller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">V</forename><surname>Darby</surname></persName>
		</author>
		<idno type="DOI">10.1136/jcp.42.1.92</idno>
		<idno type="PMID">2921349</idno>
		<idno type="PMCID">PMC1141799</idno>
		<idno type="ark">ark:/67375/NVC-0XNWHB7Z-B</idno>
		<idno type="istexId">CEBA40EC1DC30DDDEC674516D19535B8A891D02A</idno>
		<ptr type="open-access" target="https://jcp.bmj.com/content/jclinpath/42/1/92.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Pathology</title>
		<title level="j" type="abbrev">Journal of Clinical Pathology</title>
		<idno type="ISSN">0021-9746</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="96" />
			<date type="published" when="1989-01-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Cilj ovog istraživanja je validirati rezultate određivanja protrombinskog vremena (PV) međunarodnim normaliziranim omjerom (engl. international normalized ratio, INR) dobivene reagensima tvrtke Steelex na njihovom koagulometru (Steelex Scientifi c Instrument Company, Peking, Kina) u usporedbi s često primjenjivanim standardnim testom tvrtke Pacifi c Hemostasis</title>
	</analytic>
	<monogr>
		<title level="m">Evaluacija rezultata dobivenih koagulometrom M600H tvrtke Steelex pri određivanju protrombinskog vremena INR Steelexovim reagensima Sažetak Uvod</title>
		<meeting><address><addrLine>Middletown, Virginia; Neufahrn, Njemačka</addrLine></address></meeting>
		<imprint>
			<publisher>Fisher Diagnostics</publisher>
		</imprint>
	</monogr>
	<note type="report_type">Teco Medical Instruments GmbH</note>
	<note>SAD) na koagulometru proizvođača Teco Coatron A4</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Sakupljeni su uzorci od 90 ispitanika te su im određene INR vrijednosti dvostruko slijepim određivanjem primjenjujući oba sustava. Rezultati: Koefi cijenti varijacije u seriji (CV) kod određivanja INR varirali su kod Steelexovog sustava od 2,6% (INR = 1,12) do 3,1% (INR = 2,51) i kod testa tvrtke Pacifi c od</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Materijali I Metode</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Za oba su testa izračunati koefi cijenti varijacije (CV) iz dana u dan i u seriji primjenjujući kontrolne uzorke od proizvođača testa</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
		</imprint>
	</monogr>
	<note>1% (INR = 1,09) do 1,8% (INR = 2,8)</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Passing Bablokovom regresijom Steelexove metode i metode proizvođača Pacifi c dobivena je jednadžba: Steelex INR = 0,85 (0,79-0,91) × Pacifi c INR + 0,12 (-0,02-0,21), gdje je P vrijednost CUSUM-ovog testa linearnosti bila &lt; 0,01, a srednja sustavna pogrješka određena Bland-Altmanovim testom iznosila je -0</title>
	</analytic>
	<monogr>
		<title level="m">9% (INR = 2,64) a za test tvrtke Pacifi c od</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
		</imprint>
	</monogr>
	<note>3% (INR = 1,1) do 2,3% (INR = 2,7). 156 jedinica (-0,912-0</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m">Zaključak: Rezultati dobiveni primjenom Steelexovih reagensa na koagulometru M600H nisu, što se terapeutskog raspona tiče, ekvivalentni rezultatima dobivenim primjenom reagensa tvrtke Pacifi c Hemostasis na koagulometru Teco Coatron A4. Ključne riječi: Steelexov koagulometar</title>
		<imprint/>
	</monogr>
	<note>protrombinsko vrijeme; INR; evaluacija</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
